Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response
- PMID: 19341773
- PMCID: PMC2694223
- DOI: 10.1016/j.jconrel.2009.03.016
Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response
Abstract
Fast forming hydrogels prepared by crosslinking a poly(ethylene glycol) (PEG)-based copolymer containing multiple thiol (SH) groups were evaluated for the controlled ocular delivery of pilocarpine and subsequent pupillary constriction. Physical properties of the hydrogels were characterized using UV-Vis spectrophotometry, transmission electron microscopy (TEM), rheometry, and swelling kinetics. Pilocarpine loading efficiency and release properties were measured in simulated tear fluid. The hydrogel formulations exhibited high drug loading efficiency (approximately 74%). Pilocarpine release was found to be biphasic with release half times of approximately 2 and 94 h, respectively, and 85-100% of the drug was released over 8-days. Pilocarpine-loaded (2% w/v) hydrogels were evaluated in a rabbit model and compared to a similar dose of drug in aqueous solution. The hydrogels were retained in the eye for the entire period of the study with no observed irritation. Pilocarpine-loaded hydrogels sustained pupillary constriction for 24 h after administration as compared to 3 h for the solution, an 8-fold increase in the duration of action. A strong correlation between pilocarpine release and pupillary response was observed. In conclusion, the current studies demonstrate that in situ forming PEG hydrogels possess the viscoelastic, retention, and sustained delivery properties required for an efficient ocular drug delivery system.
Figures








Similar articles
-
In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.Int J Pharm. 2001 Oct 23;229(1-2):29-36. doi: 10.1016/s0378-5173(01)00825-0. Int J Pharm. 2001. PMID: 11604255
-
In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine.J Pharm Sci. 1998 Feb;87(2):226-30. doi: 10.1021/js970090e. J Pharm Sci. 1998. PMID: 9519158
-
Self-assembled hexagonal liquid crystalline gels as novel ocular formulation with enhanced topical delivery of pilocarpine nitrate.Int J Pharm. 2019 May 1;562:31-41. doi: 10.1016/j.ijpharm.2019.02.033. Epub 2019 Mar 14. Int J Pharm. 2019. PMID: 30878587
-
Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles.J Pharm Pharmacol. 2006 Feb;58(2):179-86. doi: 10.1211/jpp.58.2.0004. J Pharm Pharmacol. 2006. PMID: 16451745
-
Mucoadhesive microparticles in a rapidly dissolving tablet for sustained drug delivery to the eye.Invest Ophthalmol Vis Sci. 2011 Apr 22;52(5):2627-33. doi: 10.1167/iovs.10-6465. Print 2011 Apr. Invest Ophthalmol Vis Sci. 2011. PMID: 21245405 Free PMC article.
Cited by
-
Design and in vitro evaluation of capsaicin transdermal controlled release cubic phase gels.AAPS PharmSciTech. 2010 Sep;11(3):1405-10. doi: 10.1208/s12249-010-9481-1. Epub 2010 Sep 14. AAPS PharmSciTech. 2010. PMID: 20839080 Free PMC article.
-
Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.J Ocul Pharmacol Ther. 2014 Feb;30(1):49-58. doi: 10.1089/jop.2013.0157. Epub 2013 Nov 5. J Ocul Pharmacol Ther. 2014. PMID: 24192229 Free PMC article.
-
Influence of molecular size on the retention of polymeric nanocarrier diagnostic agents in breast ducts.Pharm Res. 2012 Sep;29(9):2377-88. doi: 10.1007/s11095-012-0763-z. Epub 2012 May 9. Pharm Res. 2012. PMID: 22569800 Free PMC article.
-
3D printing of nanocomposite pills through desktop vat photopolymerization (stereolithography) for drug delivery reasons.3D Print Med. 2022 Jan 17;8(1):3. doi: 10.1186/s41205-022-00130-2. 3D Print Med. 2022. PMID: 35038049 Free PMC article.
-
Alginate-Based Composites for Corneal Regeneration: The Optimization of a Biomaterial to Overcome Its Limits.Gels. 2022 Jul 10;8(7):431. doi: 10.3390/gels8070431. Gels. 2022. PMID: 35877516 Free PMC article. Review.
References
-
- Maurice DM. In: Ophthalmic drug delivery: biopharmaceutical, technological, and clinical aspects. Saettone MF, Bucci M, Speiser P, editors. Vol. 11. Liviana Press; Padova: 1987. pp. 19–26.
-
- Vandamme TF, Brobeck L. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release. 2005;102(1):23–38. - PubMed
-
- Chrai SS, Robinson JR. Corneal permeation of topical pilocarpine nitrate in the rabbit. Am J Ophthalmol. 1974;77(5):735–739. - PubMed
-
- Nanjawade BK, Manvi FV, Manjappa AS. In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Release. 2007;122(2):119–134. - PubMed
-
- Sieg JW, Robinson JR. Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine. J Pharm Sci. 1977;66(9):1222–1228. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources